title: Rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis successfully treated with polymyxin B-immobilized fiber column hemoperfusion.
abstract: Amyopathic dermatomyositis (ADM) is a clinical subtype of dermatomyositis, characterized by the absence of motor weakness and the presence of normal muscle enzyme levels. ADM is sometimes accompanied by interstitial pneumonia that shows a rapid progressive course associated with a poor prognosis. We describe a 70-year-old man who presented rapidly progressive interstitial pneumonia associated with clinically ADM (C-ADM); he was successfully treated with polymyxin B-immobilized fiber column (PMX) hemoperfusion.
authors.affiliation: Department of Internal Medicine, Emergency and Critical Care Medical Center, Kitakyushu Municipal Yahata Hospital, Fukuoka.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Kakugawa
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Mukae
authors.forename: Masataka
authors.initials: M
authors.lastname: Saito
authors.forename: Koji
authors.initials: K
authors.lastname: Ishii
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ishimoto
authors.forename: Noriho
authors.initials: N
authors.lastname: Sakamoto
authors.forename: Takahiro
authors.initials: T
authors.lastname: Takazono
authors.forename: Yuichi
authors.initials: Y
authors.lastname: Fukuda
authors.forename: Nobuharu
authors.initials: N
authors.lastname: Ooe
authors.forename: Shigeru
authors.initials: S
authors.lastname: Kohno
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000150:complications*; D018450:Disease Progression; D006464:Hemoperfusion / Q000379:methods*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000209:etiology* / Q000628:therapy*; D008297:Male; D011112:Polymyxin B / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D011112:Polymyxin B